A cross-ideological group of ethicists recently signed a powerful public letter opposing the proposed federal regulation banning the sale of hematopoietic stem cells, used in bone marrow transplantation. These cells are used in the treatment of patients with serious blood or bone marrow cancer. Often, cell transplantation is needed to save the patient’s life. The new rule would reverse a 2011 court decision holding that offering payment to bone marrow donors is not forbidden by the National Organ Transplantation Act, if it is done by means of a new, relatively noninvasive procedure known as apheresis.
Ethicists make the case for bone marrow transplantation markets
Ethicists make the case for bone marrow transplantation markets
Recent Publications
- “Equal Opportunity, Not Reparations” in the Handbook of Equality of Opportunity (2024)
- “A Bayesian Solution to Hallsson’s Puzzle”
- Markets without Limits: Moral Virtues and Commercial Interests, 2nd Edition
- “Optimizing political influence: a jury theorem with dynamic competence and dependence”
- Why not anarchism?
Recent News
- Advocacy group concerned pay-for-plasma clinics expanding to Ontario will hurt voluntary donations
- Jason Brennan and Hélène Landemore, Debating Democracy (University of Zurich’s UBS Center, 2024)
- Jason Brennan “Everything Wrong with Democracy” on the Alex O’Connor Podcast (January 28, 2024)
- On the affirmative action ruling, the Supreme Court got it half right
- Is the effective altruism movement in trouble?